In This Section

Home / Learn


ACCC education and advocacy support offers our multidisciplinary membership a variety of diverse and enriching resources that address the complex changes and challenges in delivering quality cancer care.

Our ever-growing ACCC community of nearly 30,000 practitioners and healthcare professionals have access to member-driven education programs delivered in a wide range of formats. These formats include live national and regional meetings, webinars, workshops, publications, white papers, case studies, surveys, environmental scans, and literature reviews, as well as onsite learning opportunities, peer-to-peer learning, focus groups, and more.

ACCC members are invited to get involved. Contact us at to learn more.

Cancer Types

ACCC offers education and resources to help multidisciplinary cancer care teams stay informed of disease-specific advances, deploy strategies for effective integration into practice, and engage in bi-directional learning.

Community Oncology Research

ACCC is dedicated to helping the oncology community advance new therapies, expand access to clinical trials, and to close the gap in cancer care delivery by offering the latest education and resources on real-world research, evidence, and clinical trials.

Comprehensive Cancer Care Services

Cancer care services that address the full spectrum of a patient’s needs—physical, nutritional, emotional, psychosocial, spiritual, and financial—have been found to greatly improve survivor’s quality of life and outcomes.

Financial Advocacy

Through the Financial Advocacy Network tools and resources, ACCC's goal is to empower providers to proactively integrate financial health into the oncology care continuum and help patients gain access to high-quality care for a better quality of life.

Health Equity

By supporting our members and the entire oncology specialty, we can prioritize equity, diversity, and inclusion in quality cancer care delivery, as well as within the oncology workforce.

Management & Operations

ACCC is leading the way in transforming oncology practice management and operations resources that connect real-world challenges with real-world solutions.

Precision Medicine

Helping to bring personalized cancer care into focus, ACCC transforms complex science into clear and actionable education that brings clarity to patient care decisions.

More Resources

ACCC offers a variety of webinars, continuing education opportunities, abstracts, presentations, the Oncology Issues journal, and more publications.

Webinars & E-Learning

The ACCCeLearning platform provides multidisciplinary education and resources that support the different needs of our members. With a variety of flexible online learning options that fit individual learning preferences, you have your choice of in-depth courses or shorter learning formats to gain quick knowledge.

Explore by Topic

Latest On-Demand Webinars

  • In the third webinar, we will hear from Jennifer Paquet, RN, BSN, Financial Assistance Patient Care Coordinator Supervisor from Bassett Cancer Institute and Aimee Hoch, MSW, LSW, Oncology Financial Navigator from Grand View Health Cancer Center. We will discuss barriers to radiology prior authorizations and provide insights on how to address them.

  • In the second webinar, we will hear from Andre D. Harvin, PharmD, MS, Executive Director of Pharmacy for Oncology at Cone Health. We will discuss how your pharmacy team can be a major ally and support in obtaining prior authorizations, help navigate biosimilar changes, and address medical necessity.

  • In the first webinar, we will hear from Sarah Hudson-DiSalle, PharmD, Rph, Pharmacy Manager, from The James Cancer Hospital, and Jordan Karwedsky, Financial Counselor from Green Bay Oncology. In this webinar, we discuss ACCC Prior Authorization Focus Group findings, payer recommendations, and how to best prepare for the prior authorization "blizzard" for next year.

Continuing Education Activities

ACCC’s mission is to promote the education and training of the multidisciplinary oncology care team, with the goal of improving the treatment and management of patients with cancer. Our portfolio includes education for all learners, regardless of the stage they are in their career.

Collaboration of Multidisciplines for Biomarker Testing Implementation Needed for Effective Treatment Decisions in Metastatic Colorectal Cancer (mCRC)

Collaboration of Multidisciplines for Biomarker Testing Implementation Needed for Effective Treatment Decisions in Metastatic Colorectal Cancer (mCRC)

In this workshop, provided by the France Foundation, interactive formats will allow the multidisciplinary care team to continuously assess knowledge gaps. At the end of this workshop, participants will be able to develop a personalized action plan for incorporating new insights and competencies into practice, learn to develop practical biomarker testing protocols for metastatic colorectal cancer, and how this information can support personalized treatment decisions for improved patient outcomes.

Credits Available: This activity is awarded 4.5 hours of AMA PRA Category 1 Credit(s)™ and nursing contact hours. For additional CE information, please visit

More Information

Emerging Therapies for the Management of Castration-Sensitive Prostate Cancer

Emerging Therapies for the Management of Castration-Sensitive Prostate Cancer

Included in this course are data from the PEACE-1 phase 3 trial exploring triple therapy, ongoing trials in metastatic castration-sensitive prostate cancer, and quality of life studies on systemic therapies.

This activity provides guidance on the optimal management of mCSPC to oncologists, urologists, oncology advanced practitioners and other members of the multidisciplinary cancer care team. The program addresses some of the challenges in optimal sequencing of care in mCSPC and provides an opportunity to discuss with leading oncology experts and colleagues how new research clinical updates can be translated into new patient care strategies.


  • Archana Ajmera, MSN, ANP-BC-AOCNP, Advanced Practice Provider Supervisor, Division of Hematology/Oncology, UCSD Moores Cancer Center
  • Pedro C. Barata, MD, MSC, Assistant Professor, Deming Department of Medicine Division of Hematology/Oncology, Genitourinary Cancers Tulane University, Tulane University
  • Erik Castle, MD, FACS, Professor of Urology, Tulane University
  • Lisa M. Holle, PHARMD, BCOP, FHOPA, FISOPP, Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, UConn School of Medicine

View Course

Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management

Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management

This enduring material was recorded from an interactive, virtual (live) summit to enhance coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC.

  • Session 1:  Learn what factors influence testing selection for patients with advanced NSCLC.
  • Session 2:  Gain clarity on biomarker testing methodology and recommendations.
  • Session 3:  Hear insights on advanced NSCLC treatment opportunities and optimizing patient care.

Credits Available: This activity offers up to 4.5 hours of CME/CMLE credit.
Enroll Today

Presentations and Abstracts

ACCC presents oral and poster presentations that represent the spectrum of cancer care at international conferences throughout the year.



ACCC members consistently give ACCC publications high marks for their timeliness and usefulness. Experts in the field of oncology contribute to ACCC's publications and provide a solution-based approach to educating oncology healthcare professionals about streamlining and improving cancer services, practice management trends and strategies; implementing new treatments and technology; and planning for regulatory and legislative change.

Oncology Issues

Oncology Issues is the official journal of the Association of Community Cancer Centers (ACCC). As one of the only non-clinical, programmatic journals covering cancer, Oncology Issues provides “how-to” articles for the entire multidisciplinary oncology care team, on a wide range of topics.


The Hospital of the Future

By Amanda Patton, MA

Industry leaders share insights on the transformation of hospitals and health systems. All agree that the healthcare of the future will be delivered in ambulatory settings—outside of the traditional four walls of a hospital or clinic—and that success will rest on implementing a technology-enabled delivery system to provide accessible, equitable care to patients across the entire health continuum.

Also in This Issue:

  • Addressing Social Determinants of Health Through a Medical-Legal Partnership
    Through a collaboration between legal and healthcare professionals, this Virginia based medical-legal partnership assists patients with cancer resolve social and environmental factors that contribute to health disparities.
  • Calm Minds and Grateful Hearts: The Value of Medical-Legal Partnerships
    An interview with Kathyrn Smolinski, MSW, JD on the development and implementation of the medical-legal partnership between Wayne State University Law School and the Karmanos Cancer Institute.
  • Reimagining Healthcare for Incidental Lung Nodules
    WellSpan Health embarked on a multispecialty effort to reimagine the management and care of patients with incidental findings, thereby optimizing population health, lowering the cost of care, and improving the patient and provider experiences.
  • JUST Ask!
    Learn how one cancer program operationalized this joint ASCO-ACCC implicit bias aimed at ensuring patients with cancer in underrepresented groups have equitable access to care and clinical trials.
  • Developing a Health Literacy and Clear Communication e-Course
    ACCC’s online course provides cancer care team members with the tools needed to be clear and concise in communication with patients, build awareness and skills regarding health literacy, and improve health equity.
  • An Innovative Approach to Navigating Patients Through Cancer Diagnostics
    TriHealth Cancer and Blood Institute improved the coordination of its biomarker testing program by implementing digital strategies and hiring a precision medicine test coordinator—decreasing turnaround times from 24 to 12 days from orders to results
  • Examining Patient-Centered Small Cell Lung Cancer: Patient and Provider Perspectives
    Key findings from an ACCC survey and education program


  • Update Your Processes for Reporting Single-Dose Container Waste for 2023


  • CoxHealth, Hulston Cancer Center, Springfield, Missouri


  • Expressing Life’s Inexplicable Events Through Art

Browse Current Issue Online  View Archived Issues (Member Login Required)


Patient Assistance & Reimbursement Guide



Trending Now in Cancer Care Survey